Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 3Sarcoma 2Myeloid 2Lymphoid 1Gynecologic 1Gastrointestinal 1

Conditions

Gastrointestinal Stromal Tumors 71Sarcoma 12Brain Neoplasms 10Gliosarcoma 9Glioblastoma 9Neoplasm Metastasis 6Glioma 6Dermatofibrosarcoma 6Oligodendroglioma 5Central Nervous System Neoplasms 5Astrocytoma 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Fibrosarcoma 4Chordoma 4Sarcoma, Synovial 3Osteosarcoma 3Neurofibrosarcoma 3Neuroectodermal Tumors, Primitive, Peripheral 3Neoplasms 3Liposarcoma 3Hemangiosarcoma 3Glioma, Subependymal 3Digestive System Neoplasms 3Desmoid Tumors 3Sarcoma, Endometrial Stromal 2Recurrence 2Primary Myelofibrosis 2Piebaldism 2Multiple Myeloma 2Meningioma 2

Interventions

Cyclophosphamide 39Peripheral Blood Stem Cell Transplantation 32fludarabine phosphate 30Busulfan 26Filgrastim 24Cyclosporine 24Mycophenolic Acid 22Antilymphocyte Serum 22Radiotherapy 20Melphalan 16Whole-Body Irradiation 15Tacrolimus 14Methylprednisolone 14Methotrexate 13Cord Blood Stem Cell Transplantation 12Etoposide 10sargramostim 5Thiotepa 5Temozolomide 5Sirolimus 5Rituximab 5Bevacizumab 5aldesleukin 4Therapeutics 4Granulocyte Colony-Stimulating Factor 4Cytarabine 4Carmustine 4pembrolizumab 3Vincristine 3Topotecan 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recurrence × Imatinib Mesylate × Sarcoma × Clear all
NCT01172548 2017-05-31

INV555

Novartis

Phase 2 Completed
132 enrolled
GastrointestinalSarcoma

Recurrence, Gastrointestinal Stromal Tumors

NCT00243191 2012-03-29

Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans

Sarcoma Alliance for Research through Collaboration

Phase 2 Completed
18 enrolled 7 charts
Sarcoma

Recurrence, Dermatofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡